Citation | Sperandio, D; Aktoudianakis, V; Babaoglu, K; Chen, X; Elbel, K; Chin, G; Corkey, B; Du, J; Jiang, B; Kobayashi, T; Mackman, R; Martinez, R; Yang, H; Zablocki, J; Kusam, S; Jordan, K; Webb, H; Bates, JG; Lad, L; Mish, M; Niedziela-Majka, A; Metobo, S; Sapre, A; Hung, M; Jin, D; Fung, W; Kan, E; Eisenberg, G; Larson, N; Newby, ZER; Lansdon, E; Tay, C; Neve, RM; Shevick, SL; Breckenridge, DG Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg Med Chem27:457-469 (2019) [PubMed] Article |
---|
SMILES | COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C |r,wD:7.7,(46.55,-39.62,;46.55,-41.16,;47.89,-41.93,;49.21,-41.16,;50.55,-41.92,;51.88,-41.15,;52.18,-39.65,;51.41,-38.32,;49.87,-38.32,;52.18,-36.98,;51.41,-35.66,;52.17,-34.32,;53.72,-34.32,;54.49,-35.66,;53.72,-36.99,;53.7,-39.47,;54.46,-38.13,;54.34,-40.87,;53.21,-41.9,;53.22,-43.46,;51.89,-44.23,;50.55,-43.47,;49.22,-44.25,;47.88,-43.47,;46.55,-44.24,;46.51,-45.79,;47.74,-46.72,;45.04,-46.23,;44.16,-44.97,;45.09,-43.74,;44.64,-42.27,)| |